Yeast

No measurable IgG antibodies to yeast were identified. This suggests minimal immune reactivity. Yeast-containing foods are less likely to be contributing to delayed food-related symptoms for most individuals.

A very low result indicates trace immune recognition and is generally considered clinically insignificant. Most individuals with very low yeast IgG tolerate yeast-containing foods without issue.

A low result reflects mild exposure and immune familiarity. This level is common and usually does not require elimination. If symptoms are suspected, reducing frequency of highly yeast-containing foods or rotating intake may be sufficient.

A moderate Yeast IgG result indicates a measurable immune response to yeast proteins that is above background exposure but not in the highest reactivity range. Because yeast is found in many commonly consumed foods—such as bread, baked goods, pizza dough, pastries, beer, wine, and some fermented products—a moderate level often reflects regular dietary exposure. The key question is whether this level correlates with symptoms.

In individuals who frequently consume yeast-containing foods and feel well, a moderate result may not be clinically significant. However, if digestive or systemic symptoms tend to occur after eating foods that contain yeast, this level may be worth exploring. Some people with moderate yeast IgG reactivity report bloating, gas, abdominal discomfort, reflux, fatigue, brain fog, headaches, sinus congestion, or skin changes appearing hours to a day after consumption. These symptoms are not specific to yeast and can overlap with gluten sensitivity, fermentable carbohydrate intolerance, or broader gut imbalances, so patterns over time are important.

A structured elimination and reintroduction trial is often the most practical way to determine whether a moderate yeast result is clinically relevant. This typically involves removing major yeast-containing foods for a defined period, commonly 4–6 weeks. During this time, attention is paid to symptom changes while maintaining a nutritionally balanced diet. After the elimination phase, yeast-containing foods are reintroduced in a controlled way—ideally starting with a single source such as bread or baked goods—to observe whether symptoms return. Clear improvement during elimination and recurrence upon reintroduction suggests that yeast may be contributing to symptoms. If no change occurs, the moderate IgG finding may simply reflect exposure rather than sensitivity.

Moderate yeast IgG reactivity can also be influenced by overall gut and immune health. Disruptions in the gut microbiome, increased intestinal permeability, high intake of refined carbohydrates, chronic stress, or ongoing inflammation may heighten immune responses to yeast. Addressing digestive health, improving dietary diversity, and reducing reliance on processed yeast-containing foods may help reduce reactivity over time and improve tolerance.

It is important to clarify that a moderate yeast IgG result does not diagnose Candida overgrowth, fungal infection, or a true yeast allergy. IgG testing reflects immune recognition, not infection. Anyone with symptoms suggestive of fungal overgrowth or with immediate allergic-type reactions should seek appropriate medical evaluation.

Overall, a moderate yeast IgG level should be viewed as a prompt to investigate symptom patterns rather than a permanent directive to avoid yeast. Careful tracking, temporary elimination, and thoughtful reintroduction provide the most reliable way to determine whether this level has meaningful impact on health.

A high result reflects strong IgG reactivity to yeast. In symptomatic individuals, this may suggest that yeast-containing foods are contributing to ongoing digestive or inflammatory symptoms. Temporary elimination and gradual reintroduction are often considered. High IgG does not diagnose yeast overgrowth or infection, and additional clinical evaluation is needed if those conditions are suspected.